8. Multidisciplinary Approach for the Treatment of Neuroendocrine Tumors

Modlin I.M. , Oberg K. , Chung D.C. , Jensen R.T. , de Herder W.W. , Thakker R.V. , Caplin M. , Delle Fave G. , Kaltsas G.A. , Krenning E.P. , Moss S.F. , Nilsson O. , Rindi G. , Salazar R. , Ruszniewski P. , Sundin A. : Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol, 9: 61–72, 2008.

Solcia E. , Klöppel G. , Sobin L.H. : Histological Typing of Endocrine Tumours. World Health Organization International Histological Classification of Tumours. Springer-Verlag, Berlin, 2000.

Rindi G. , Klöppel G. , Alhman H. , Caplin M. , Coulevard A. , de Herder W.W. , Eriksson B. , Falchetti A. , Falconi M. , Komminoth P. , Körner M. , Lopes J.M. , McNicol A-M , Nilsson O. , Perren A. , Scarpa A. , Scoazec J-Y , Wiedenmann B and all other Frascati Consensus Conference participants: TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 449: 395–401, 2006.

Rindi G. , Klöppel G. , Coulevard A. , Komminoth P. , Körner M. , Lopes J.M. , McNicol A-M , Nilsson O. , Perren A. , Scarpa A. , Scoazec J-Y , Wiedenmann B. : TMN staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 451: 757–762, 2007.

Pape U.F. , Jann H. , Müller-Nordhorn J. , Bockelbrink A. , Berndt U. , Willich S.N. , Koch M. , Röcken C. , Rindi G. , Wiedenmann B. : Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer, 113: 256–265, 2008.

Fisher L. , Kleeff J. , Esposito I. , Hinz U. , Zimmermann A. , Friess H. , Büchler M.W. : Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surgery, 95: 627–635, 2008.

Kwekkeboom D.J. , Kam B.L. , van Essen M. , Teunissen J.J. , van Eijck C.H. , Valkema R. , de Jong M. , de Herder W.W. , Krenning E.P. : Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Endocr Relat Cancer, 17: 53–73, 2010.

Krausz Y. , Keidar Z. , Kogan I. , Even-Sapir E. , Bar-Shalom R. , Engel A. , Rubinstein R. , Sachs J. , Bocher M. , Agranovicz S. , Chisin R. , Israel O. : SPECT/CT hybrid imaging with 111In-pente-treotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf), 59: 565–573, 2003.

Buchmann I. , Henze M. , Engelbrecht S. , Eisenhut M. , Runz A. , Schäfer M. , Schilling T. , Haufe S. , Herrmann T. , Haberkorn U. : Comparison of 68Ga-DOTATOC PET and 111In-DT-PAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging, 34: 1617–1626, 2007.

Mazzaferro V. , Pulvirenti A. , Coppa J. : Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol, 47: 454–475, 2007.

McDermott E.W. , Guduric B. , Brennan M.F. : Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg, 81: 1007–1009, 1994.

Moertel C.G. : Treatment of the carcinoid tumor and the malignant carcinoid syndrome. Clin Oncol, 1(11): 727–40, 1983.

Öberg K. : The use of chemotherapy in the management of neuroendocrine tumors. Endocrinal Metab Clin North Am, 22: 941–952, 1993.

Martin J.K. , Moertel C.G. , Adson M.A. , Schutt A.J. : Surgical treatment of functioning metastatic carcinoid tumors. Arch Surg, 118: 537–542, 1983.

Danforth D.N. , Gorden P. , Brennan M.F. : Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery, 96: 1027–1037, 1984.

Norton J.A. , Sugarbaker P.H. , Doppman J.L. , Welsey R.A. , Maton P.N. , Gardner J.D. , Jensen R.T. : Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg, 203: 353–359, 1986.

Makridis C. , Öberg K. , Juhlin C. , Rastad J. , Johansson H. , Lörelius L.E. , Akerström G. : Surgical treatment of mid-gut carcinoid tumors. World J Surg, 14: 377–386, 1990.

McEntee G.P. , Nagorney D.M. , Kvols L.K. , Moertel C.G. , Grant C.S. : Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery, 108: 1091–1096, 1990.

Søreide O. , Berstad T. , Bakka A. , Schrumpf E. , Hanssen L.E. , Engh V. , Bergan A. , Flatmark A. : Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery, 111: 48–54, 1992.

Carty S.E. , Jensen R.T. , Norton J.A. : Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery, 112: 1024–1032, 1992.

Que F.G. , Nagorney D.M. , Batts K.P. , Linz L.J. , Kvols L.K. : Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg, 10: 36–43, 1995.

Dousset B. , Saint-Marc O. , Pitre J. , Soubrane O. , Houssin D. , Chapuis Y. : Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg, 20: 908–915, 1996.

Chen H. , Hardacre J.M. , Uzar A. , Cameron J.L. , Choti M.A. : Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg, 187: 88–93, 1998.

Sarmiento J.M. , Heywood G. , Rubin J. , Ilstrup D.M. , Nagorney D.M. , Que F.G. : Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg, 197: 29–37, 2003.

Jaeck D. , Oussoultzoglou E. , Bachellier P. , Lemarque P. , Weber J.C. , Nakano H. , Wolf P. : Hepatic metastases of gastropancreatic neuroendocrine tumors: safe hepatic surgery. World J Surg, 25: 689–692, 2001.

Yao K.A. , Talamonti M.S. , Nemcek A. , Angelos P. , Chrisman H. , Skarda J. , Benson A.B. , Rao S. , Joehl R.J. : Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery, 130: 677–682, 2001.

Chamberlain R.S. , Canes D. , Brown K.T. , Saltz L. , Jarnagin W. , Fong Y. , Blumgart L.H. : Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg, 190: 432–445, 2000.

Roth T. , Marmorale A. , Gavelli A. , Huguet C. : The surgical treatment of liver metastasis of carcinoid tumors. Ann Chir, 127: 783–785, 2002.

Norton J.A. , Warren R.S. , Kelly M.G. , Zuraek M.B. , Jensen R.T. : Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery, 134: 1057–1065, 2003.

Steinmüller T. , Kianmanesh R. , Falconi M. , Scarpa A. , Taal B. , Kwekkeboom D.J. , Lopes J.M. , Perren A. , Nikou G. , Yao J. , Delle Fave G. , O'Toole D. , and all other Frascati Consensus Conference participants: Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary. Neuroendocrinology, 87: 47–62, 2008.

Lehnert T. : Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation, 66: 1307–1312, 1998.

Olausson M. , Friman S. , Cahlin C. , Nilsson O. , Jansson S. , Wängberg B. , Ahlman H. : Indications and results of liver transplantation in patients with neuroendocrine tumors. World J Surg, 26: 998–1004. 2002.

Rosenau J. , Bahr M.J. , von Wasielewski R. , Mengel M. , Schmidt H.H. , Nashan B. , Klempnauer J. , Manns M.P. , Boeker K.H. : Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation, 15: 386–394, 2002.

Cahlin C. , Friman S. , Ahlman H. , Backman L. , Mjornstedt L. , Lindner P. , Herlenius G. , Olausson M. : Liver transplantation for metastatic neuroendocrine tumor disease. Transplant Proc, 35: 809–810, 2003.

Fernandez J.A. , Robles R. , Marin C. , Hernandez Q. , Sanchez Bueno F. , Ramirez P. , Rodriguez J.M. , Lujan J.A. , Navalon J.C. , Parilla P. : Role of liver transplantation in the management of metastatic neuroendocrine tumors. Transplant Proc, 35: 1832–1833, 2003.

Florman S. , Toure B. , Kim L. , Gondolesi G. , Roayaie S. , Krieger N. , Fishbein T. , Emre S. , Miller C. , Schwartz M. : Liver transplantation for neuroendocrine tumors. J Gastrointest Surg, 8: 208–212, 2004.

Van Vilsteren F.G.I. , Baskin-Bey E.S. , Nagorney D.M. , Sanderson S.O. , Kremers W.K. , Rosen C.B. , Gores G.J. , Hobday T.J. : Liver transplantation for gastropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl, 12: 448–456, 2006.

Le Treut Y.P. , Delpero J.R. , Dousset B. , Cherqui D. , Segol P. , Mantion G. , Hannoun L. , Benhamou G. , Launois B. , Boillot O. , Domergue J. , Bismuth H. : Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg, 225: 355–364, 1997.

Le Treut Y.P. , Grégoire E. , Belghiti J. , Boillot O. , Soubrane O. , Mantion G. , Cherqui D. , Castaing D. , Ruszniewski P. , Wolf P. , Paye F. , Salame E. , Muscari F. , Pruvot F.R. , Baulieux J. : Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transpl, 8: 1205–1213, 2008.

Frilling A. , Li J. , Malamutmann E. , Schmid K-W , Bockisch A. , Broelsch C.E. : Treatment of liver metastases from neuroendocrine tumors in relation to the extent of hepatic disease. Br J Surg, 96: 175–184, 2009.

Mazzaferro V. , Pulvirenti A. , Coppa J. : Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol, 47(4): 460–466, 2007.

Cooper W.A. , Thourani V.H. , Gal A.A. , Lee R.B. , Mansour K.A. , Miller J.I. : The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest, 119: 14–18, 2001.

Cardillo G. , Sera F. , Di Martino M. , Graziano P. , Giunti R. , Carbone L. , Facciolo F. , Martelli M. : Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg, 77: 1781–1785, 2004.

Ferguson M.K. , Landreneau R.J. , Hazelrigg S.R. , Altorki N.K. , Naunheim K.S. , Zwischenberger J.B. , Kent M. , Yim A.P. : Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothoracic Surg, 18: 156–161, 2000.

McMullan D.M. , Wood D.E. : Pulmonary carcinoid tumors. Semin Thorac Cardiovasc Surg, 15: 289–300, 2003.

Daddi N. , Ferolla P. , Urbani M. , Semeraro A. , Avenia N. , Ribacchi R. , Puma F. , Daddi G. : Surgical treatment of neuron-docrine tumors of the lung. Eur J Cardiothorac Surg, 26: 813–817, 2004.

Mineo T.C. , Guggino G. , Mineo D. , Vanni G. , Ambrogi V. : Relevance of lymph node micrometastases in radically resected endobronchial carcinoid tumors. Ann Thorac Surg, 80: 428–432, 2005.

Arrigoni M.G. , Woolner L.B. , Bernatz B.E. : Atypical carcinoid tumours of the lung. J Thorac Cardiovasc Surg, 64: 413–421, 1972.

Travis W.D. , Colby T.V. , Corrin B. , Shimosato Y. , Brambilla E. : World Health Organization, Histological Typing of lung and pleural tumours, 3rd ed, Berlin, Springer, 1999.

Modlin I.M. , Sandor A. : An analysis of 8305 cases of carcinoid tumors. Cancer, 79: 813–829, 1997.

Modlin I.M. , Öberg K. , Chung D.C. , Jensen R.T. , de Herder W.W. , Thakker R.V. , Caplin M. , Delle Fave G. , Kaltsas G.A. , Krenning E.P. , Moss S.F. , Nilsson O. , Rindi G. , Salazar R. , Ruszniewski P. , Sundin A. : Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol, 9: 61–72, 2008.

Quaedvlieg PFHJ , Visser O. , Lamers CBHW , Janssen-Heijen M.L.G. , Taal B.G. : Epidemiology and survival in patients with carcinoid disease in the Netherlands. Ann Oncol, 12: 1295–1300, 2001.

Skuladottir H. , Hirsch F.R. , Hansen H.H. , Olsen J.H. : Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer, 37: 127–135, 2002.

Modlin I.M. , Lye K.D. , Kidd M. : A 5-decade analysis of 13,715 carcinoid tumors. Cancer, 297: 934–959, 2003.

Ferolla P. , Faggiano A. , Avenia N. , Milone F. , Masone S. , Giampaglia F. , Puma F. , Daddi G. , Angeletti G. , Lombardi G. , Santeusanio F. , Colao A. : Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumors. Clin Endocrinol, 66: 1–6, 2007.

Personal communication: Dr T Sano, Tokushima Univ., Japan.

Hage R. , de la Riviere A.B. , Seldenrijk C.A. , van den Bosch J.M. : Update in pulmonary carcinoid tumors: A review article. Ann Surg Oncol, 10(6): 697–704, 2003.

Travis W.D. , Rush W. , Flieder D.B. , Falk R. , Fleming M.V. , Gal A.A. , Koss M.N. : Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol, 22: 934–944, 1998.

Garcia-Yuste M. , Matilla J.M. , Alvarez-Gago T. , Duque J.L. , Heras F. , Cerezal L.J. , Ramos G. : Prognostic factors in neuroendocrine lung tumors: A Spanish multicenter study. Ann Thorac Surg, 70: 258–263, 2000.

Asamura H. , Kameya T. , Matsuno Y. , Noguchi M. , Tada H. , Ishikawa Y. , Yokose T. , Jiang S-X , Inoue T. , Nakagawa K. , Tajima K. , Nagai K. : Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol, 24: 70–76, 2006.

Cardillo G. , Sera F. , Di Martino M. , Graziano P. , Giunti R. , Carbone L. , Facciolo F. , Martelli M. : Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg, 77(5): 1781–1785, 2004.

Lim E. , Yap Y.K. , De Stavola B.L. , Nicholson A.G. , Goldstraw P. : The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors. J Thorac Cardiovasc Surg, 130(4): 969–972, 2005.

García-Yuste M. , Molins L. , Matilla J.M. , González-Aragoneses F. , López-Pujol J. , Ramos G. , de la Torre M. ; Estudio Multicéntrico Español de los Tumores Neuroendocrinos del Pulmón de la Sociedad Española de Neumología y Cirurgía Torácica (EMETNE-SEPAR): Trends in prognostic factors for neuroendocrine lung tumors. Arch Bronconeumol, 43(10): 549–556, 2007.

Mezzetti M. , Raveglia F. , Panigalli T. , Giuliani L. , Lo Giudice F. , Meda S. , Conforti S. : Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification. Ann Thorac Surg, 76(6): 1838–1842, 2003.

Martini N. , Yellin A. , Ginsberg R.J. , Bains M.S. , Burt M.E. , McCormack P.M. , Rusch V.W. : Management of non-small cell lung cancer with direct mediastinal involvement. Ann Thorac Surg, 58(5): 1447–1451, 1994.

Beasley M.B. , Thunnissen F.B. , Brambilla E. , Hasleton P. , Steele R. , Hammar S.P. , Colby T.V. , Sheppard M. , Shimosato Y. , Koss M.N. , Falk R. , Travis W.D. : Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol, 31(10): 1255–1265, 2000.

Goldstraw P. , Crowley J. , Chansky K. , Giroux D.J. , Groome P.A. , Rami-Porta R. , Postmus P.E. , Rusch V. , Sobin L. ; The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol, 2(8): 706–714, 2007.

Grandberg D. , Wilander E. , Öberg K. , Skogseid B. : Prognostic markers in patients with typical bronchial carcinoid tumors. J Clin Endocrinol, 85: 3425–3430, 2000.

Przygodzki R.M. , Finkelstein S.D. , Langer J.C. , Swalsky P.A. , Fishback N. , Bakker A. , Guinee D.G. , Koss M. , Travis W.D. : Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol, 148: 1531–1541, 1996.

Beasley M.B. , Lantuejoul S. , Abbondanzo S. , Chu W-S , Hasleton P.S. , Path F.R.C. , Travis W.D. , Brambilla E. : The P16/cyclin D1/Rb Pathway in Neuroendocrine Tumors of the Lung. Hum Pathol, 34: 136–142, 2003.

Furlan D. , Bernasconi B. , Uccella S. , Cerutti R. , Carnevali I. , Capella C. : Allelotypes and fluorescence in situ hybridization profiles of poorly differentiated endocrine carcinomas of different sites. Clin Can Res, 11: 1765–1775, 2005.

Faggiano A. , Sabourin J-C , Ducreux M. , Lumbroso J. , Duvillard P. , Leboulleux S. , Dromain C. , Colao A. , Schlumberger M. , Baudin E. : Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas. Diagnostic and prognostic features. Cancer, 110: 265–274, 2007.

Igarashi T. , Jiang S.X. , Kameya T. , Asamura H. , Sato Y. , Nagai K. , Okayasu I. : Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. Mod Pathol, 17(10): 1259–1267, 2004.

Rodriguez E. , Lilenbaum R.C. : Small cell lung cancer: past, present, and future. Curr Oncol Rep, 12(5): 327–334, 2010.

Ekeblad S. , Sundin A. , Tiensuu Janson E. , Welin S. , Granberg D. , Kindmark H. , Dunder K. , Kozlovacki G. , Örlefors H. , Sigurd M. , Öberg K. , Eriksson B. , Skogseid B. : Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. Clin Cancer Res, 13(10): 2986–2991, 2007.